Pharmaids Pharmaceuticals Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Cash & Equivalents	-	21.45	48.04	127.54	4.07	2
Short-Term Investments	-	-	-	33.05	-	-
Cash & Short-Term Investments	2.39	21.45	48.04	160.59	4.07	2
Cash Growth	-91.44%	-55.36%	-70.09%	3841.48%	103.44%	819.72%
Accounts Receivable	-	31.28	26.79	20.54	13.39	2.77
Receivables	-	31.28	26.79	20.54	13.39	2.77
Inventory	-	121.84	35.91	-	8.88	3.69
Prepaid Expenses	-	4.02	1.57	-	-	-
Other Current Assets	-	44.48	23.01	2.02	0.34	0.11
Total Current Assets	-	223.07	135.32	183.16	26.68	8.57
Property, Plant & Equipment	-	491.8	384.59	21.06	4.81	4.9
Goodwill	-	314.17	314.17	-	-	-
Other Intangible Assets	-	5.45	5.45	-	-	-
Long-Term Accounts Receivable	-	-	-	-	14.16	7.58
Long-Term Deferred Tax Assets	-	105.03	66.68	27.08	3.56	3.51
Long-Term Deferred Charges	-	-	-	1.21	-	-
Other Long-Term Assets	-	59	7.21	0.85	61.92	66.59
Total Assets	-	1,199	913.41	245.85	111.12	91.15
Accounts Payable	-	163.21	51.18	18.83	23.06	5.02
Accrued Expenses	-	6.58	4.62	0.28	-	-
Short-Term Debt	-	40.57	11.53	-	-	-
Current Portion of Long-Term Debt	-	10.06	6.14	-	-	-
Current Portion of Leases	-	7.93	7.13	-	-	-
Current Income Taxes Payable	-	0.26	-	-	-	-
Other Current Liabilities	-	58.53	35.16	2.14	1.35	0.87
Total Current Liabilities	-	287.15	115.76	21.25	24.41	5.89
Long-Term Debt	-	301.84	35.85	-	-	-
Long-Term Leases	-	29.35	24.68	-	-	-
Pension & Post-Retirement Benefits	-	7.78	6.15	-	-	-
Other Long-Term Liabilities	-	22	26	-0	-	-0
Total Liabilities	-	648.11	208.44	21.25	24.41	5.89
Common Stock	-	352.68	352.68	214.44	102.69	102.69
Additional Paid-In Capital	-	505.75	505.75	104.24	-	-
Retained Earnings	-	-266.77	-139.3	-98.89	-23.33	-24.78
Comprehensive Income & Other	-	1.55	1.34	4.81	7.36	7.36
Total Common Equity	519.19	593.2	720.47	224.6	86.72	85.26
Minority Interest	-	-42.79	-15.5	-	-	-
Shareholders' Equity	513.11	550.42	704.97	224.6	86.72	85.26
Total Liabilities & Equity	-	1,199	913.41	245.85	111.12	91.15
Total Debt	201.32	389.75	85.33	-	-	-
Net Cash (Debt)	-198.93	-368.3	-37.29	160.59	4.07	2
Net Cash Growth	-	-	-	3841.48%	103.44%	819.72%
Net Cash Per Share	-5.62	-10.44	-1.64	12.45	0.40	0.19
Filing Date Shares Outstanding	35.41	35.27	35.27	21.49	10.31	10.31
Total Common Shares Outstanding	35.41	35.27	35.27	21.49	10.31	10.31
Working Capital	-	-64.07	19.56	161.91	2.27	2.69
Book Value Per Share	14.65	16.82	20.43	10.45	8.41	8.27
Tangible Book Value	205.03	273.59	400.85	224.6	86.72	85.26
Tangible Book Value Per Share	5.79	7.76	11.37	10.45	8.41	8.27
Land	-	254.5	178.22	-	-	-
Buildings	-	7.72	6.08	-	-	-
Machinery	-	184.48	116.88	-	5.09	5.09
Construction In Progress	-	45.3	70.01	-	4.5	4.5

Source: S&P Global Market Intelligence. Standard template. Financial Sources.